Abstract-We tested the hypothesis that vascular endothelial function, assessed by endothelium-dependent dilation, is related to serum vitamin D status among middle-aged and older adults without clinical disease, and that this is linked to inflammation. Brachial artery flow-mediated dilation, a measure of endothelium-dependent dilation, was lower (PϽ0. Key Words: aging Ⅲ endothelium-dependent dilation Ⅲ NFB Ⅲ interleukin-6 Ⅲ 1-␣ hydroxylase Ⅲ VDR C ardiovascular diseases (CVDs) remain the leading cause of death in modern societies, and advancing age is the major risk factor for CVD. [1][2][3] The increase in CVD risk with aging is attributable in large part to the development of vascular endothelial dysfunction, most commonly assessed as impaired endothelium-dependent dilation. 2,4,5 Consistent with this, middle-aged and older adults demonstrate reduced brachial artery flow-mediated dilation (FMD), a measure of endothelium-dependent dilation, 6 compared with young adults. 7 However, there is considerable variability in brachial artery FMD among middle-aged/older adults, and the contributing factors to impaired brachial FMD in this at-risk group are incompletely understood.
C ardiovascular diseases (CVDs) remain the leading cause of death in modern societies, and advancing age is the major risk factor for CVD. [1] [2] [3] The increase in CVD risk with aging is attributable in large part to the development of vascular endothelial dysfunction, most commonly assessed as impaired endothelium-dependent dilation. 2, 4, 5 Consistent with this, middle-aged and older adults demonstrate reduced brachial artery flow-mediated dilation (FMD), a measure of endothelium-dependent dilation, 6 compared with young adults. 7 However, there is considerable variability in brachial artery FMD among middle-aged/older adults, and the contributing factors to impaired brachial FMD in this at-risk group are incompletely understood.
Vitamin D deficiency is an independent predictor of CVD and all-cause mortality. 8 -10 Patients with chronic clinical diseases who are vitamin D deficient and young adults with severe vitamin D deficiency demonstrate impaired brachial artery FMD. [11] [12] [13] The physiological mechanisms by which vitamin D deficiency is linked to brachial artery FMD in these settings have not been established but may involve vascular inflammation. In humans, vitamin D deficiency is associated with increased circulating inflammatory proteins, 10, 14, 15 whereas in cultured vascular endothelial cells, vitamin D inhibits activation of the proinflammatory transcription factor nuclear factor B (NFB), 16 as well as the release of the inflammatory cytokine interleukin-6 (IL-6), 17 a downstream target of NFB activation. However, it is unknown whether vitamin D deficiency is associated with impaired brachial artery FMD among middle-aged/older adults without CVD and, if so, whether this is related to vascular inflammation.
In the present study, we tested the hypothesis that brachial artery FMD is inversely related to vitamin D status (as reflected by serum concentrations of 25-hydroxyvitamin D [25(OH)D]) among middle-aged/older adults in the absence of clinical diseases. We also tested the hypothesis that vitamin D deficiency and impaired brachial FMD are associated with vascular inflammation in this group. To do so, we determined brachial artery FMD in healthy middle-aged/older men and women differing in serum 25(OH)D levels. We then assessed the expression of NFB and IL-6 in vascular endothelial cells obtained from subgroups of these subjects, as well as NFB signaling-associated suppression of brachial artery FMD using salsalate, an inhibitor of NFB activation. To provide additional insight into the molecular mechanisms linking circulating 25(OH)D to endothelial function, we measured 1-␣ hydroxylase, the enzyme that converts 
Methods

Subjects
Subjects were 75 middle-aged/older (50 to 79 years) men (nϭ47) and postmenopausal women (nϭ28; 92% white, 5% Asian, and 3% Hispanic). Subjects had a systolic blood pressure Ͻ159 mm Hg, diastolic blood pressure Ͻ99 mm Hg, and were otherwise free of CVD, diabetes, kidney disease, and other chronic clinical disorders as assessed by medical history, physical examination, blood chemistries, and resting and exercise ECG. All subjects were nonsmokers not taking medications (prescription or over the counter), hormone replacement therapy, or dietary supplements (including those with antioxidant properties). Subjects were not performing regular aerobic exercise (ie, Ͻ30 minutes per day, Ͻ2 days per week for Ն2 years before study participation). All procedures were approved by the Human Research Committee of the University of Colorado at Boulder. The nature, benefits, and risks of the study were explained to the volunteers, and their written informed consent was obtained before participation.
Study Procedures
All measurements were performed at the University of Colorado at Boulder Clinical and Translational Research Center after an overnight fast (water only) and a 24-hour abstention from alcohol and vigorous physical activity.
Subject Characteristics, Blood Assays, and Dietary Analysis
Subjects were classified by 25(OH)D concentration as deficient (Ͻ20 ng/mL), insufficient (20 to 29 ng/mL), or sufficient (Ͼ29 ng/mL) in accordance with recent recommended guidelines. 18 (For details of subject characteristics, blood analyses, and dietary analysis, please see the online supplement, available at http://hyper.ahajournals.org.)
Brachial Artery FMD and Endothelium-Independent Dilation
Brachial artery FMD (upper forearm cuff position), peak shear rate during FMD, and endothelium-independent dilation (brachial artery dilation in response to sublingual nitroglycerin) were determined using duplex ultrasonography (Power Vision 6000; Toshiba) with a linear array transducer as described previously. 19, 20 Responses are expressed as millimeters and percent change from baseline diameter per recent recommended guidelines. 21 
Vascular Endothelial Cell Protein Expression
Vascular endothelial cells were obtained from antecubital venous sampling and analyzed for expression of proteins (IL-6, NFB p65, tumor necrosis factor-␣ [TNF-␣], vitamin D receptor, or 1-␣ hydroxylase) using quantitative immunofluorescence as described previously. 20, [22] [23] [24] Interindividual and group differences in protein expression using this procedure reflect expression in endothelial cells obtained from brachial artery sampling in the same subject. 25 (For details of the methodology, see the online supplement.)
Salsalate Administration
To determine the contribution of NFB-associated proinflammatory signaling to 25(OH)D-related differences in endothelium-dependent dilation, a subgroup of 21 middle-aged/older (50 to 68 years) men (nϭ17) and postmenopausal women (nϭ4) were randomly assigned to receive oral doses of salsalate, an NFB inhibitor, or placebo using a 4-day cross-over design as described previously. 20 (For details, see the online supplement.)
Statistics
All of the data are presented as meansϮSEM. (For details on statistical analysis, please see the online supplement.)
Results
Subject Characteristics
General subject characteristics, blood pressure, metabolic factors, and kidney function are presented in Table 1 . Mean serum 25(OH)D in the overall sample was 25.3Ϯ1.0 ng/mL 
Humoral Factors
Humoral factors are shown in Table 2 . C-Reactive protein, TNF-␣, oxidized LDL, total antioxidant status, endothelin-1, and norepinephrine did not differ among the groups. Plasma IL-6 was higher in the deficient group (PϽ0.01 versus sufficient) and was inversely related to 25(OH)D in the overall sample (rϭϪ0.40; PϽ0.01).
Diet Composition
Dietary analysis is shown in supplemental Table I Figure 1 ). This relationship remained significant after correcting for subject characteristics in Table 1 Figure 2 , left panel). When subjects were divided by the median value of 25(OH)D, brachial FMD was 42% lower in the group with lower compared with higher circulating vitamin D (PϽ0.05; Figure 2 , middle panel). NFB inhibition with salsalate improved FMD in both groups (PϽ0.05 versus placebo), but the increase was greater (PϽ0.05) in subjects with lower (ϩ168%) compared with higher (ϩ50%) serum 25(OH)D. As a result, FMD was similar in the 2 groups after treatment with salsalate. There were no differences in baseline diameter or shear rate between groups or conditions (salsalate versus placebo). Groups did not differ in any subject characteristics, and serum 25(OH)D concentrations did not differ between placebo and salsalate conditions. The results were similar when mm⌬ was used instead of %⌬.
Salsalate treatment reduced the expression of NFB in vascular endothelial cells obtained from subjects with lower (Pϭ0.06) but not from those with higher serum 25(OH)D (Figure 2 , right panel). There were no differences in endothelial cell expression of NFB in the 2 groups after treatment with salsalate. 
Vascular Endothelial Cell IL-6 and TNF-␣ Expression
Discussion
The 
Vitamin D and Vascular Endothelial Dysfunction With Aging
The results of the present study demonstrate that brachial artery FMD, a measure of endothelium-dependent dilation and vascular endothelial function, is inversely related to serum vitamin D status among middle-aged/older adults without clinical disease. This is consistent with recent work in patients with diabetes and chronic kidney disease 11, 12 and in young adults with severe vitamin D deficiency. 13 Our findings extend these observations by showing an inverse association between circulating vitamin D and vascular endothelial function that is evident in healthy adults within a typical range of serum 25(OH)D. 26 Our data indicate a specific relationship between brachial artery FMD and serum 25(OH)D, the metabolite used to determine vitamin D status, but not 1,25(OH) 2 D, the biologically active form of vitamin D. 1,25(OH) 2 D is formed via conversion of 25(OH)D by the enzyme 1-␣ hydroxylase, a process historically viewed as occurring in the kidney with the presumed aim of maintaining muscle and bone health. However, it has been recognized recently that this conversion also can occur locally in several different cells and tissues. 18, 27 This implies that 1,25(OH) 2 D can exert autocrine/ paracrine cell-specific functions when produced outside of the kidney. 28 In the context of the present work, vascular endothelial cells in culture express vitamin D receptors and 1-␣ hydroxylase. 29, 30 Here, we demonstrate for the first time expression of these proteins in vascular endothelial cells collected from human subjects. Because circulating 1,25(OH) 2 It should be noted that previous investigations in patients with chronic kidney disease on hemodialysis and healthy young adults with severe vitamin D deficiency found that brachial FMD was related to both serum 25(OH)D and 1,25(OH) 2 D levels. 11, 13 The differences between our results and those of previous investigations on this point may be explained by differing kidney function (ie, kidney disease versus healthy) or the degree of vitamin D deficiency. Differences in oxidative stress between vitamin D-sufficient and vitamin D-deficient groups also may have been greater in these previous studies, as reflected by increased circulating markers of oxidant damage. 13 In contrast, plasma-oxidized LDL, a marker of oxidant modification of lipids, did not differ among the groups in the present study.
Vitamin D and Vascular Inflammation
Our results are the first to show a relation between serum vitamin D status and vascular endothelial inflammation in humans. Specifically, we found that vascular endothelial cell expression of the p65 subunit of NFB, a major proinflammatory nuclear transcription factor, and IL-6, a proinflamma- To determine whether differences in NFB-related signaling in the vascular endothelium between subjects with lower compared with higher 25(OH)D may have contributed to differences in vascular endothelial function, we inhibited NFB activation using short-term treatment with salsalate. 20 Salsalate reduces endothelial cell NFB in adults with elevated baseline expression. 20 Consistent with this, in the present study, we observed a selective reduction in NFB in endothelial cells obtained in subjects with lower serum 25(OH)D concentrations, a group with elevated baseline expression of NFB. Most important, we found that the tonic suppression of endothelium-dependent dilation by NFB signaling, as assessed by the improvement in brachial artery FMD from placebo control in response to short-term treatment with salsalate, was greater in the subgroup with lower circulating 25(OH)D, and that salsalate treatment abolished group differences in FMD. This provides direct evidence of NFB activation-related vascular endothelial dysfunction in middle-aged/older adults with lower serum 25(OH)D.
Limitations
In the present study, selective subject characteristics were or tended to be different between groups. However, these trends did not explain group differences in brachial FMD because correcting for these factors did not weaken the relationship between FMD and serum 25(OH)D concentrations. Parenthetically, the tendency for differences in such characteristics in the present study among healthy adults is consistent with evidence in human studies and animal models (eg, vitamin D receptor knockout mice) that vitamin D deficiency is associated with cardiovascular risk factors such as increased blood pressure and insulin resistance. 31, 32 Expression of proteins, including NFB, in endothelial cells obtained from the antecubital vein generally reflects expression in cells obtained from the brachial artery of the same subject. 22, 25 However, in the present study, we assessed only cells from venous sampling and, thus, cannot confirm the presence of differences in arterial endothelial cells among groups differing in serum vitamin D status.
Finally, we did not measure for proteinuria, and kidney function was estimated by the Modification of Diet in Renal Disease equation, which is less accurate in persons with normal or mildly impaired kidney function compared with patients with more severe dysfunction. Therefore, we cannot rule out differences in kidney function among the 3 serum 25(OH)D groups.
Conclusions
In conclusion, the results of the present study support the hypothesis that serum 25 
Supplemental Methods.
Subject Characteristics, Blood Assays and Dietary Analysis. Body mass index (BMI) was calculated from height and weight to the nearest 0.1 kg, and waist and hip circumferences were measured by anthropometry 1 . Total body fat and bone mineral density were determined using dual energy x-ray absorptiometry (DPX-IQ, GE/Lunar, Inc.) 1 . Arterial blood pressure was measured over the brachial artery during seated rest using a semi-automated device (Dynamap XL, Johnson and Johnson) 2 . Habitual physical activity was assessed from estimates of daily energy expenditure using the Stanford Physical Activity Questionnaire as previously described 3 . Diet composition and caloric intake were estimated from 3-day food intake records (The Food Processor 8.2, ESHA Research) as described previously 1 .
Serum samples were analyzed for 25(OH)D and 1,25(OH)D 2 by the Associated Regional and University Pathologists (ARUP) laboratories (Salt Lake City, UT) using liquid chromatography/tandem mass spectrometry and radioimmunoassay, respectively. The inter-and intra-batch coefficients of variation averaged 7.0% and 4.5% for 25(OH)D. Because serum 25(OH)D levels fluctuate seasonally 4 , the sampling date for each subject was classified according to season (winter (December-February), spring (March-May), summer (June-August), autumn (September-November)).
All other assays were performed by the University of Colorado CTRC core laboratory. Plasma total cholesterol, low-density lipoprotein cholesterol (LDL-C), highdensity lipoprotein cholesterol (HDL-C), triglycerides, glucose and insulin were determined using standard assays. Serum concentrations of C-reactive protein were measured using a highsensitivity Chemistry Immuno Analyzer (AU400e, Olympus America, Inc.). Serum interleukin-6 (IL-6; R&D Systems, Inc), tumor-necrosis factor-α (TNF-α, R&D Systems, Inc), oxidized LDL (Alpco, Inc), and endothelin-1 (Peninsula Laboratories, Inc), were measured by ELISA. Total antioxidant status was measured using an enzymatic kit (Randox Laboratories, Inc.), and plasma norepinephrine concentrations were measured by high performance liquid chromatography (BioRad Laboratories).
Vascular Endothelial Cell Protein Expression. Briefly, J-wires were advanced into the antecubital vein ~4 cm beyond the tip of an 18-guage catheter and withdrawn. Cells were recovered by washing and centrifugation, fixed with 3.7% formaldehyde and plated on slides. Non-specific binding sites were blocked with 5% donkey serum (Jackson Immunoresearch) and cells were incubated with monoclonal antibodies for IL-6 (Santa Cruz) (n=24), NFκB p65(Novus) (n=64), TNFα (Abcam) (n=37), vitamin D receptor (Santa Cruz) (n=12) or 1-α hydroxylase (The Binding Site) (n=10). Slides were systematically viewed with a fluorescence microscope (Eclipse 600, Nikon, Melville, NY) to identify endothelial cells (positive staining for von Willebrand factor) and nuclear integrity was confirmed with DAPI (4',6'-diamidino-2-phenylindole hydrochloride) staining. Images were then captured and analyzed with Metamorph Software (Universal Imaging Corp, Downington, PA) to quantify the intensity of CY3 staining (i.e., average pixel intensity). The values for each protein are reported as a ratio of endothelial cell to human umbilical vein endothelial cell (HUVEC) average pixel intensity, which minimizes the possible confound of differences in intensity of staining among different staining sessions. A single investigator analyzed each batch of cells and was blinded to subject identification. Salsalate Administration. Salsalate was administered in a total daily dose (2500-4500 mg) that has been used clinically to inhibit NFκB by producing steady state plasma salicylate concentrations in the therapeutic range of 10 to 30 mg/100 mL 7, 8 , while minimizing gastrointestinal and other side effects 9, 10 . Subjects received a standardized diet prepared by the CTRC bionutritionist for 3 days prior to the vascular testing sessions.
Statistics.
Statistical analyses were performed with PASW Statistics (version 18.0). For the main study, differences across the three groups of 25(OH)D and tertiles of 1,25(OH) 2 D were determined by one-way ANOVA and between two groups of 25(OH)D using an unpaired t-test. Least squares difference post hoc tests were used where appropriate. Differences in the categorical variable (season) across groups were determined using the chi-squared test of independence. Potential bivariate relations of interest between variables, including relations between subject characteristics (potential confounders) and the independent ((25(OH)D) and dependent (FMD) variables, were assessed using Pearson product-moment correlation analyses. The relation between non-dichotomous nominal and interval variables was assessed by the eta correlation. Stepwise multiple regression analyses were then conducted, with variables chosen based on subject characteristics that tended to differ in Table 1 and those variables known or thought to be associated with vascular endothelial function, based on published observations (characteristics included in the model were age, mass, BMI, body fat, waist circumference, waist-to-hip ratio, physical activity, systolic blood pressure, diastolic blood pressure, total cholesterol, LDL cholesterol, triglycerides, glucose, insulin and HOMA). Partial correlation analysis was used to statistically remove the potential influence of a variable on the relation between 25(OH)D and FMD. For the salsalate sub-protocol, subjects were divided into higher and lower vitamin D groups based on the median value for 25(OH)D and a t-test was used for independent sample comparisons. Statistical significance for all analyses was set at P < 0.05.
Supplemental Results.
Figure Legends Data are mean ± S.E. kcal, kilocalories. 
